7 September 2021 (Tuesday) - The Oncologist Update

The nice people at “The Oncologist  sent their update today. Much of it went over my head, but (as I always say) it is all useful background reading.

Precision Medicine Clinic: Molecular Tumor Board



Clinical Trial Results


Antibiotics and Imiquimod for Cutaneous T‐Cell Lymphoma in Veterans

Christina A. Del Guzzo, Arsenije Kojadinovic, Ravi R. Vinnakota et al.

Study to Compare Capsule and Liquid Formulations of Enzalutamide in Prostate Cancer

Lisa M. Cordes, Keith T. Schmidt, Cody J. Peer et al.

Efficacy and Safety of Trametinib in Non‐V600 BRAF Mutant Melanoma: A Phase II Study

Caroline A. Nebhan, Douglas B. Johnson, Ryan J. Sullivan et al.



Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.

Ahmed M. Afifi, Ahmed O. Elmehrath, Inas A. Ruhban et al.

Prognostic Role of CTCs in mRCC: A Large, Multicenter, Prospective Trial

Umberto Basso, Antonella Facchinetti, Elisabetta Rossi et al.


Machine Learning Identification of Gene Signatures in Metastatic Prostate Cancer

Edwin Lin, Andrew W. Hahn, Roberto H. Nussenzveig et al.

Patients' and Providers' Perspectives in Tobacco Cessation

Alexandra B. Khodadadi, William Carroll, Erica L. Lee et al.

Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical? Practice Guidelines

Aaron P. Mitchell, Akriti Mishra, Pranam Dey et al.

The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards

Shruti R. Patel, Frederique St. Pierre, Ana I. Velazquez et al.

Genomics of Intrahepatic Cholangiocarcinoma

Mason A. Israel, Natalie Danziger, Kimberly A. McGrego et al.

Nivolumab Plus Ipilimumab for the Treatment of HCC Previously Treated with Sorafenib

May Tun Saung, Lorraine Pelosof, Sandra Casak et al.

No comments:

Post a Comment